Sicart Associates Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$9.78M |
| 2 |
Gilead Sciences
GILD
|
+$7.93M |
| 3 |
Bunge Global
BG
|
+$5.87M |
| 4 |
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
|
+$5.27M |
| 5 |
AT&T
T
|
+$4.46M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
APA Corp
APA
|
+$4.01M |
| 2 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$3.62M |
| 3 |
SLB Ltd
SLB
|
+$2.18M |
| 4 |
FedEx
FDX
|
+$1.41M |
| 5 |
Zillow
Z
|
+$919K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.75% |
| 2 | Consumer Staples | 12.3% |
| 3 | Materials | 11.18% |
| 4 | Communication Services | 9.85% |
| 5 | Technology | 7.53% |
Similar funds
Sicart Associates's Q4 2020 Portfolio in Review
As of Q4 2020, Sicart Associates held 130 positions worth $405M, up 21% from $335M the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Sicart Associates deployed $19.9M of net new capital in Q4 2020, opening 14 new positions and adding to 32 existing holdings. Its largest new stake was State Street Energy Select Sector SPDR ETF: 567,400 shares worth $10.8M.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 21% a quarter earlier, followed by Consumer Staples and Materials.
On the sell side, the largest reduction was APA Corp, an estimated $4.01M trimmed.
- Sicart Associates's largest Q4 2020 buy was State Street Energy Select Sector SPDR ETF: 567,400 shares worth $10.8M.
- Sicart Associates added most to Gilead Sciences in Q4 2020, an estimated $7.93M increase.
- Sicart Associates's biggest Q4 2020 reduction was APA Corp, cutting an estimated $4.01M.
- Sicart Associates fully exited Zillow in Q4 2020, selling an estimated $919K.
- Sicart Associates's ten largest holdings make up 46% of its $405M portfolio in Q4 2020.
- Sicart Associates opened 14 new positions and closed 10 in Q4 2020.
- Sicart Associates's portfolio value rose 21% quarter-over-quarter to $405M.
Based on Sicart Associates's 13F filing for Q4 2020, filed 22 Jan 2021.